Vera Therapeutics kept at Overweight; JP Morgan lifts PT
JP Morgan maintained Vera Therapeutics at Overweight and raised its price target to $83.00 per share from $76.00, according to TradingView News via Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.